Your browser doesn't support javascript.
loading
Influence of spironolactone on neonatal screening for congenital adrenal hyperplasia.
Terai, I; Yamano, K; Ichihara, N; Arai, J; Kobayashi, K.
Affiliation
  • Terai I; Division of Clinical Pathology, Hokkaido Institute of Public Health, Sapporo 060, Japan. terai@iph.pref.hokkaido.jp
Arch Dis Child Fetal Neonatal Ed ; 81(3): F179-83, 1999 Nov.
Article in En | MEDLINE | ID: mdl-10525019
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Spironolactone / Enzyme-Linked Immunosorbent Assay / Adrenal Hyperplasia, Congenital / 17-alpha-Hydroxyprogesterone / Diuretics Type of study: Diagnostic_studies / Screening_studies Limits: Humans / Male / Newborn Language: En Journal: Arch Dis Child Fetal Neonatal Ed Journal subject: PEDIATRIA / PERINATOLOGIA Year: 1999 Document type: Article Affiliation country: Japan Country of publication: United kingdom
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Spironolactone / Enzyme-Linked Immunosorbent Assay / Adrenal Hyperplasia, Congenital / 17-alpha-Hydroxyprogesterone / Diuretics Type of study: Diagnostic_studies / Screening_studies Limits: Humans / Male / Newborn Language: En Journal: Arch Dis Child Fetal Neonatal Ed Journal subject: PEDIATRIA / PERINATOLOGIA Year: 1999 Document type: Article Affiliation country: Japan Country of publication: United kingdom